SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-034261
Filing Date
2022-03-16
Accepted
2022-03-16 08:30:28
Documents
17
Period of Report
2022-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228804d2_8k.htm   iXBRL 8-K 33814
2 EXHIBIT 5.1 tm228804d2_ex5-1.htm EX-5.1 7214
3 EXHIBIT 10.1 tm228804d2_ex10-1.htm EX-10.1 195549
4 EXHIBIT 99.1 tm228804d2_ex99-1.htm EX-99.1 7320
8 GRAPHIC tm228804d2_ex5-1img001.jpg GRAPHIC 3051
9 GRAPHIC tm228804d2_ex99-1img001.jpg GRAPHIC 15113
  Complete submission text file 0001104659-22-034261.txt   498958

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA axla-20220316.xsd EX-101.SCH 3048
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE axla-20220316_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axla-20220316_pre.xml EX-101.PRE 22605
11 EXTRACTED XBRL INSTANCE DOCUMENT tm228804d2_8k_htm.xml XML 3593
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 22743384
SIC: 2836 Biological Products, (No Diagnostic Substances)